• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

Advertisement

Collaboration › Details

Expression Pathology–Flagship Biosciences: tissue proteomics, 201012– collab offering Liquid Tissue SRM assays with digital pathology services

 

	Period	2010-12-08
	Partner, 1st	Expression Pathology Inc. (EPI)
	Partner, 2nd	Flagship Biosciences L.L.C.
	Product	digital pathology services
	Product 2	Liquid Tissue Array

Expression Pathology Inc.. (12/9/10). "Press Release: Flagship Partners with Expression Pathology to Combine Tissue Proteomics and Digital Pathology. Two Leading Companies Offer Clients Integrated Services for Digital Pathology and Quantitative Mass-spec

Expression Pathology, the leading provider of FFPE tissue-based proteomics, and Flagship Biosciences, the leading digital pathology services firm, announce a service partnership that enables tissue translational biomarker development, validation and application in support of drug development.

Many pharmaceutical, biotech and academic clinical research organizations require robust targeted assays to translate and validate their biomarker discovery efforts with respect to protein expression in tissue. Customers of Expression Pathology and Flagship can now leverage expertise with tissue biomarkers to quickly develop quantitative evidence-based assays using the combined know how of mass-spec tissue analysis and digital pathology. Flagship's pathology expertise to ensure the right tissue or sub anatomic organelle is analyzed combined with Expression Pathology's expertise in multiplex tissue proteomic assays using FFPE tissue offers an exciting and comprehensive tissue analysis service to customers.

"Expression Pathology's unique and proprietary Liquid Tissue® SRM assays for quantitative analyses of proteins in FFPE tissue are opening huge opportunities in personalized medicine to relate those measurements to patient treatment decisions" said Casey Eitner, President and CEO of Expression Pathology Inc.

"Translational and personalized medicine today requires better integration of the enabling technologies these platforms and new generation of service organizations provide," said John Bloom, a member of Flagship's Board of Directors and a well-known leader in translational medicine. "This novel partnership is prototypic of what is required to meet the needs of drug development and patient care in this dynamic area of applied biomarker science."

Expression Pathology Inc. (EPI) is a private biotechnology company leading the development of innovative assays to measure functional tissue proteins in research and diagnostic applications.

Flagship Biosciences LLC is a pathologist-owned contract research organization that delivers quantitative pathology and tissue-based companion diagnostics in drug and device development.

Record changed: 2011-11-25

More documents for Expression Pathology Inc. (EPI)

• [1] Expression Pathology Inc.. (2/13/12). "Press Release: Expression Pathology Collaborates on Liquid Tissue Personalized Medicine Assays in Lung Cancer Treatment". Rockville, MD....
• [2] Expression Pathology Inc.. (2/1/12). "Press Release: Expression Pathology Appoints New President and CEO". Rockville, MD....
• [3] Expression Pathology Inc.. (3/24/11). "Press Release: Expression Pathology Obtains Second U.S. Liquid Tissue Patent". Rockville, MD....
• [4] Expression Pathology Inc.. (2/1/11). "Press Release: Expression Pathology and Children’s Oncology Group to Measure IGF-1R Expression in Pediatric Clinical Rhabdomyosarcoma Tissue". Rockville, MD....
• [5] Expression Pathology Inc.. (1/11/11). "Press Release: Expression Pathology Provides Roche Its Liquid Tissue-SRM Protein Biomarker Assay Services in Drug Development". Rockville, MD....
• [6] Expression Pathology Inc.. (12/9/10). "Press Release: Flagship Partners with Expression Pathology to Combine Tissue Proteomics and Digital Pathology. Two Leading Companies Offer Clients Integrated Services for Digital Pathology and Quantitative Mass-spec...
• [7] Expression Pathology Inc.. (9/27/10). "Press Release: Expression Pathology’s Liquid Tissue Patent Issues in Japan". Rockville, MD....
• [8] Thermo Fisher Scientific Inc.. (5/20/10). Thermo Scientific Annual MS User’s Meeting & ASMS Customer Appreciation Event. [http://www.thermoscientific.com, 05/20/10]...
• [9] Expression Pathology Inc.. (5/4/10). "Press Release: Expression Pathology Collaborates with Toronto’s Sick Kids Hospital and University Health Network on New Mass Spec EGFR Test". Rockville, MD....
• [10] Expression Pathology Inc.. (11/17/09). "Press Release: Liquid Tissue Patent Licensed for Amyloidosis Proteomic Assay. Expression Pathology’s Method Enables Mass Spec Analysis of Amyloid Proteins in Microdissected FFPE Tissue". Rockville, MD....

To subscribe to our free, monthly [MSC] Newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

NEW: Visit our brand new forthcoming web portals Life-Sciences-Germany.com and Life-Sciences-Europe.com

» top

» Imprint  |  » Contact  |  The use of this website requires to accept the disclaimer!   |  A project of [iito] Business Intelligence © 2002-2012. Made in Germany.